Skip to main content
. 2006 Sep;86(2):181–195. doi: 10.1901/jeab.2006.108.05

Table 1. Order and description of each comparison. For each comparison the FR requirement, dose, and resulting unit price of each alternative are shown. Also shown is the relative price (larger-dose alternative / smaller-dose alternative). Absolute prices (and relative prices in Phase 3) have been rounded to the nearest whole number.

Phase Comp. Order
Alt. 1
Alt. 2
Unit price
Price
3572 3600 3603 FR Dose FR Dose Alt. 1 Alt. 2 (L/S)
1 1 1 1 1 30 0.3 30 0.1 100 300 0.3
2 6 7 7 100 0.3 100 0.1 333 1000 0.3
3 2 4 4 10 0.1 30 0.1 100 300
4 4 5 2 10 0.3 30 0.1 33 300 0.1
5 3 6 6 30 0.1 100 0.3 300 333 1.1
6 22 29 31 30 0.1 200 0.3 300 667 2.2
7 5 2 3 30 0.1 300 0.3 300 1000 3.3
8 7 3 5 100 0.1 300 0.3 1000 1000 1
2 9 12 31 14 2 0.1 6 0.3 20 20 1
10 9 32 9 4 0.1 12 0.3 40 40 1
11 19 33 12 8 0.1 24 0.3 80 80 1
12 8 34 8 16 0.1 48 0.3 160 160 1
13 20,32 35 10 32 0.1 96 0.3 320 320 1
14 21 36 13 64 0.1 192 0.3 640 640 1
15 10 8,37 11 128 0.1 384 0.3 1280 1280 1
16 11 14 256 0.1 768 0.3 2560 2560 1
17 28 21 25 2 0.3 6 0.9 7 7 1
18 16 23 4 0.3 12 0.9 13 13 1
19 31 15 22 16 0.3 48 0.9 53 53 1
20 29 17 24 32 0.3 96 0.9 107 107 1
21 30 18 64 0.3 192 0.9 213 213 1
22 19 128 0.3 384 0.9 427 427 1
23 20 256 0.3 768 0.9 853 853 1
3 24 13 38 15 2 0.1 12 0.3 20 40 2
25 14 39 16 2 0.1 18 0.3 20 60 3
26 15 40 17 2 0.1 24 0.3 20 80 4
27 16,33 9 18 2 0.1 30 0.3 20 100 5
28 17,34 10,41 19 2 0.1 60 0.3 20 200 10
29 18,35 11,30 20 2 0.1 120 0.3 20 400 20
30 36 12,42 21 2 0.1 240 0.3 20 800 40
31 37 13,43 2 0.1 480 0.3 20 1600 80
32 27 22 26 2 0.3 12 0.9 7 13 2
33 23 27 2 0.3 18 0.9 7 20 3
34 26 24 28 2 0.3 24 0.9 7 27 4
35 25 25 29 2 0.3 30 0.9 7 33 5
36 24 26 30 2 0.3 60 0.9 7 67 10
37 23 27 2 0.3 120 0.9 7 133 20
38 28 2 0.3 240 0.9 7 267 40